Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2018 Nov 14;13(11):e0207398. doi: 10.1371/journal.pone.0207398

Typology of patients with behavioral addictions or eating disorders during a one-year period of care: Exploring similarities of trajectory using growth mixture modeling coupled with latent class analysis

Marion Montourcy 1,2, Jean-Benoit Hardouin 1, Julie Caillon 1,2, Juliette Leboucher 2, Morgane Rousselet 1,2, Marie Grall-Bronnec 1,2, Gaëlle Challet-Bouju 1,2,*
Editor: Marc Potenza3
PMCID: PMC6235397  PMID: 30427931

Abstract

Objectives

Addictions are not restricted to substance-use disorders, and it is now widely recognized that they also include behavioral addictions. Certain individuals with eating disorders also experiment their disorder as an addiction. The objective was to identify typologies of patients presenting with various behavioral addictions or eating disorders according to their evolution within the framework of care, and to specify the factors associated with the differential clinical trajectories.

Methods

We included 302 patients presenting with problem gambling, sexual addiction, compulsive buying, excessive videogame use or eating disorders. The patients completed a multiaxial assessment through a face-to-face structured interview and self-administered questionnaires, including sociodemographic and addiction-related characteristics, psychiatric and addictive comorbidities and several psychological characteristics. The assessment was performed at inclusion and then repeated after 6 and 12 months. The statistical analysis included a combination of growth mixture models and latent class analysis.

Results

We identified five classes of patients with different profiles related to their trajectories during a one-year period of specialized care: “complex patients”, “patients with impulsive psychological functioning”, “patients with cooperative psychological functioning”, “patients with immature psychological functioning,” and “patients with resilient psychological functioning”.

Conclusions

The typology obtained brings interesting findings to propose patient-centered care strategies adapted to these disorders. Because the typology was independent from the type of disorder, it supports the general concept of behavioral addictions, and the similarities between eating disorders and behavioral addictions. The relevance of this model should be further examined in future studies.

Introduction

Addictions are not restricted to substance use disorders, and it is now widely recognized that they also include behavioral addictions (BAs), such as gambling disorder, sexual addiction, or compulsive buying [1, 2]. The inclusion of excessive videogame use under BA has been debated [3], even if the proposed diagnostic criteria for Internet Gaming Disorder in the DSM-5 largely overlap with the concept of addiction [4]. Some authors have also noted similarities between BAs and eating disorders (ED), [57]. Indeed, certain individuals with an ED experience their disorder as an addiction and share the same addictive characteristics as individuals with substance-related disorders [5].

A BA, but also more largely all addictions, can be defined as a “process whereby a behavior, that can function both to produce pleasure and to provide escape from internal discomfort, is employed in a pattern characterized by recurrent failure to control the behavior and continuation of the behavior despite significant negative consequences” [8]. Every addiction is characterized by the loss of control over the behavior, leading to the abandonment of all other personal or business investments for the exclusive benefit of the addictive behavior. The addiction then becomes the center of the addict's existence, exposing him secondarily to multiple and severe types of damage (suicide, debt, isolation, etc.). Such definition may also overlap with EDs [5].

Addictions and EDs are characterized by a long-term evolution, which can be very different according to the various profiles of patients [1]. Treatment failures and relapses are frequent [1, 9]. In this context, it seems interesting to study the differential trajectories of patients treated for a BA or an ED. Such studies with the objective of explaining changes in the patients’ status (with or without problems) or the stability of the disorder over time exist [1013]. However, studies investigating typologies of patients according to their evolution within the framework of care are very rare or even nonexistent. Moreover, to date, trajectory studies grouping together different forms of BAs and EDs do not exist.

The objective of the present study was to characterize the typologies of patients presenting with various BAs or EDs according to their evolution within the framework of care, without a priori distinguishing them according to their disorder. The aim was to identify typical trajectories and to specify the factors associated with the differential clinical evolutions. Identifying such care trajectories among a large sample of patients presenting with BAs or EDs (whatever the disorder) would allow us to highlight either: (i) a common care trajectory for all studied disorders (both BAs and EDs): such result would support the similarities between BAs and EDs, making it possible to envisage common therapeutic tracks useful for all patients; or (ii) disorder-dependent profiles, with a distinct trajectory for each type of disorder, justifying individualized care by disorder; or (iii) different trajectories not linked to the type of disorder but, rather, based on patient profiles (profiles of personality, psychiatric comorbidities, etc.): such result would also support the similarities between the disorders and the use of common therapeutic tracks independently of the disorder, but also implies to use specific care targeted for each profile (personalized medicine).

Material and methods

Participants

The participants were recruited as part of the EVALADD (EVALuation of behavioral ADDictions) cohort (NCT01248767), which consists of a prospective follow-up of patients seeking treatment for either a BA or an ED at the Nantes University Hospital (France). Our addictology department is a reference center for both BAs and EDs in France. The inclusion of EDs in the EVALADD cohort was justified by certain clinical similarities with BAs (such as the loss of control over the eating behavior despite the negative consequences), and previous reconciliation in the literature between the two concepts [57].

Treatment options and duration is adapted to the evolution of each patient, in a patient-centered approach, and comprises mainly outpatient treatment: psychotropic medications (for psychiatric comorbidities), individual psychotherapies, behavioral and cognitive group therapies, family or couple therapies, support groups (for patients or their family), assessment with a social worker. Inpatient treatment is proposed only when required, for somatic (very low weight, hypokalemia, etc.), psychiatric (high suicidal risk, severe psychiatric comorbidities, etc.) and/or contextual (familial interactions making it difficult to keep the patient from significant harm, etc.) reasons.

The participation to the EVALADD cohort was offered systematically to all incoming patients presenting to seek treatment for either a BA or an ED, and referred to our unit for an outpatient treatment. To be included in the EVALADD cohort, patients must be over 16, have given their written informed consent (and the one of their legal representative if appropriate), be affiliated to Social Welfare, and present with a diagnosis or a subclinical form for one of the 5 disorders studied: problem gambling (PG), sexual addiction (SA), compulsive buying (CB), excessive videogame use (EVU) and eating disorders (ED). Each patient was affected to a unique type of disorder according to his/her main complaint at the beginning of treatment. No patient presented with several main complaints. Subclinical forms represent disorders that do not correspond to all required diagnosis criteria, but with several problems related to the problematic behavior that can justify a need for treatment. A specific assessment was used to perform the diagnosis of each disorder (see Table 1).

Table 1. Assessment tools used to perform the diagnosis of each behavioral addiction.

Behavioral addictions Assessment tools Threshold used a
Problem gambling (PG) Interview based on the DSM-IV [14] diagnostic criteria for pathological gambling [1517] 3/10
[1820]
Eating disorders (ED) DSM-IV diagnostic criteria for anorexia nervosa, bulimia nervosa and binge-eating disorder, partly achieved with the Mini International Neuropsychiatric Interview (MINI 5.0) [21] -
Inclusion of EDNOS
Excessive videogame use (EVU) Problem Videogame Playing (PVP) questionnaire [22] 4/9
[23]
Sexual addiction (SA) Sexual Addiction Screening Test (SAST) [24] 10/25
[24].
Compulsive buying (CB) McElroy’s criteria [25] -

a We used lower thresholds than those typically employed to include subclinical forms of behavioral addictions.

Among the 611 patients to whom participation in the study was proposed (41.7% patients with EDs and 58.3% with BAs), about 11% were ineligible to be included in the cohort, and the rate of refusal for eligible patients was very low (around 5%).

Ethics

The study was conducted in accordance with Good Clinical Practice Guidelines and the Declaration of Helsinki, with approval from the local ethics committee (Groupe Nantais d’Ethique dans le Domaine de la Santé, GNEDS, Nantes). All participants provided written informed consent, including consent from parents or guardians for the participants under age 18. No compensation was given for participation.

Procedure

As part of the EVALADD procedure, the patients completed a multiaxial psychological assessment through a face-to-face structured interview and self-administered questionnaires. The assessment content was similar for all disorders, in order to allow comparisons. The structured interviews were conducted by trained research staff with experience with BAs and EDs. The assessment was performed at inclusion (just before the beginning of treatment) and then repeated six months, 12 months and each year after inclusion, as long as the participants agree to continue.

Data collection for this study took place between autumn 2009 and spring 2015, with 516 patients included in the cohort. Only patients who completed the inclusion visit (T1), the 6-month follow-up (T2) and the 12-month follow-up (T3) were included in the present analysis. The subsequent follow-up (24 months) gave a loss of patients of almost 60%, and the remaining sample (n = 125) was considered to be too small a sample size to conduct the trajectory analyses. Ultimately, the final database for the present analysis contained 302 patients.

Measures

Table 2 briefly describes the main variables used in the present study. Measures have been chosen to allow for between-disorders comparisons, i.e. to be used indifferently with all the disorders included in this study.

Table 2. Summary of the collected variables exported from the EVALADD cohort (except those used for inclusion).

Scale Acronym Utility Dimensions Range I / SAQa Collectedb
Number of positive Goodman's criteria (E section) [8] - Behavioral addiction severity - 0 to 9 I Each visit
Health-related damage - Addiction’s impact on patient’s health - 0 to 5 I Each visit
Work/school-related damage - Addiction’s impact on the patient's professional or educational life - 0 to 5 I Each visit
Relationship-related damage - Addiction’s impact on the patient's social and family life - 0 to 10 I Each visit
Mini International Neuropsychiatric Interview [21] MINI 5.0 Diagnosis of the main axis-I psychiatric disorders - - I Baseline and T3
Wender-Utah Rating Scale—Child [26] WURS-C Retrospective screening of attention deficit hyperactivity disorder (ADHD) in childhood - 0 to 100 SAQ Only at baseline
Adult ADHD Self-Report Scale Symptom Checklist [27] ASRS-1.1 Screening of attention deficit hyperactivity disorder (ADHD) in adulthood Inattention
Hyperactivity
0 to 36 SAQ Each visit
Temperament and Character Inventory– 125 [28] TCI-125 Evaluation of character (epigenetic origin) and temperament (genetic origin) Self-directedness
Cooperation
Self-transcendence
Novelty seeking
Harm avoidance
Reward dependence
Persistence
0 to 100 SAQ Each visit
Only at baseline
Impulsivity Behavior Scale [29, 30] UPPS / UPPS-P Measure of four facets of impulsivity Negative urgency
Lack of premeditation
Lack of perseverance
Sensation seeking
0 to 16 SAQ Each visit
Rosenberg Self-Esteem Scale [31] RSES Assessment of global self-esteem - 10 to 40 SAQ Each visit
Tridimensional Levenson’s locus of control scale [32] IPAH Attribution of external or internal causality to events Internal
External-powerful others
External-luck
8 to 48 SAQ Each visit
Defense Style Questionnaire [33] DSQ-40 Defense mechanisms Mature
Neurotic
Immature
1 to 9 SAQ Only at baseline
Life events [34] EVE Measure of the impact of negative life events - 0 to 400 SAQ Only at baseline

a I = Interview: the corresponding measure is collected during the face-to-face standardized interview–SAQ = Self-Administered Questionnaires: the corresponding measure is collected through a self-administered questionnaire.

b Each visit denotes that the data are collected at baseline (T1) and at each follow-up (T2 and T3, at 6 and 12 months, respectively).

Sociodemographic characteristics

Sociodemographic characteristics were collected: age, sex, marital status, educational level, and employment status.

Disorder-related characteristics

Damage. Patients were asked about the extent to which their disorder had caused negative consequences to their life, using a 6-point Likert-type scale. Three different areas were explored: health, work/school and relationships.

Disorder course. The age of initiation of the problematic behavior, the age at which the behavior became problematic, and the age at which the patient first pursued treatment were collected. The patients were asked whether they were able to completely stop the problematic behavior for at least one month, and if so, the maximum abstinence duration was collected.

Addiction severity. Goodman’s addictive disorder criteria were used to assess the addiction’s severity for all of the BAs and the EDs [8]. The use of Goodman’s criteria in EDs have been demonstrated as relevant in previous research [5], except for the restrictive form of anorexia nervosa, for which Goodman’s criteria were considered to be inappropriate (difficulty identifying the beginning and the end of the behavior). In the present study, we used responses to item E as a dimensional score of the addiction’s severity, which can range from 0 to 9.

Psychiatric comorbidities

The French version of the MINI 5.0 [21] was used to explore the main axis-I psychiatric disorders at T1 and T3: anxiety disorders, mood disorders (plus the current risk of suicide), addictive disorders and psychotic disorders.

The French version [35] of the Wender-Utah Rating Scale-Child (WURS-C) [26] was used to perform a retrospective diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) in childhood and was supplemented by the French version [36] of the Adult ADHD Self-report Scale (ASRS-v1.1) [27], which screens for ADHD in adulthood.

Psychological characteristics

Personality. The Temperament and Character Inventory (TCI-125) [37]was used to rapidly explore four temperament traits (novelty seeking, harm avoidance, reward dependence and persistence) and three character traits (self-directedness, cooperation and self-transcendence). We used the 125-item French version [38].

Impulsivity. The French version [39] of the Impulsivity Behavior Scale (UPPS) [29] was used to measure impulsivity. During the data collection, we moved to the UPPS-P French short version of the scale [30]. To standardize the results, we have reconstructed the four available scores of the new UPPS-P (“negative urgency,” (lack of) “premeditation,” (lack of) “perseverance” and “sensation seeking”) based on the initial UPPS for the first patients.

Self-esteem. The Rosenberg Self-Esteem Scale (RSES) [31] is a 10-item self-report questionnaire that explores the global self-esteem of a person. A validated French version of this scale was used for our study [40].

Locus of control. The French-Canadian version [41] of the Levenson’s questionnaire (IPAH) [32]was used to explore locus of control in three dimensions: internally, powerful others and chance.

Defense mechanisms. The Defense Style Questionnaire (DSQ) [33] explores the predominant defense style for each participant: mature, neurotic or immature. We used the French 40-items version [42].

Negative life events. We used a revised version of the French Life Events questionnaire (EVE) [34], which was previously used in another study on the EVALADD cohort [16]. The revised EVE questionnaire explores 6 areas (family, professional life, social life, marital and emotional life, health, other traumatic events) and allows to compute a total cumulative score of traumatic events by summing the intensity of trauma experienced for each of the 40 items.

Statistical analysis

We used a two-step approach to establish a typology of patients evolving differently over time. The first step was to identify different trajectories of patients for each variable. The second step was to supplement this analysis by a classification grouping together patients with similar profiles of evolution. Finally, we described the obtained classes. The database has been prepared in SAS 9.3, while the different statistical analyzes were carried out with the Mplus 7.3 software [43]. A schematic representation of the strategy used for the statistical analyses is given in Fig 1.

Fig 1. Diagram schematically describing the strategy of the statistical analyses.

Fig 1

Caption: Growth Mixture Model (GMM): - x is the first variable used for the GMM. - traj1 and traj2 represent the different trajectories obtained after the GMM analysis for the variable x. - x1, x2, etc. represent the different assignment probabilities associated with each trajectory for the variable x. Change indicator: - change1 (0–0): the variable is absent at T1 and at T3. - change2 (1–0): the variable is present at T1 and absent at T3. - change3 (0–1): the variable is absent at T1 and present at T3. - change4 (1–1): the variable is present at T1 and at T3.

Step 1: Identification of trajectories for each variable

We focused only on variables that can evolve over time: (i) scores from the UPPS and the ASRS, the character dimensions of the TCI, and the intensity of damage for continuous variables and (ii) psychiatric comorbidities (MINI) for categorical variables.

For continuous variables, we used Growth Mixture Models (GMMs) through a structural equation modeling framework [44] to identify different patterns of change among a potentially heterogeneous population. For each variable, several models were tested with a varying number of different trajectories (1 to 4), various shape of each trajectory (quadratic, linear, constant), the application of a random effect on the intercept only or on the intercept and slope, and equal or different residuals’ variances. We then followed a backward procedure, going from the most complex model (quadratic shape, different residuals’ variances and random effect on intercept and slope) to the simplest. Step by step, we excluded the trajectories which were not statistically significant according to the Wald test (with type I error fixed at 0.05). We finally obtained a set of several models composed of 1 to 4 trajectories for each variable. To select the most appropriate model for each variable, we used 4 main criteria: the lowest Sample-Size Adjusted Bayesian Information Criteria (SABIC) [45], the sample size of the less represented trajectory of more than 4% of the total sample (n = 13); at least 8 out of 10 models that converged to consider a model to be stable [46] and clinical interpretability and relevance [47, 48]. Outcomes of GMMs are assignment probabilities, which represent the probabilities that a patient will belong to each trajectory composing the model (rather than the assignment of a patient to a unique trajectory). For example, with a model composed of 3 types of trajectories (trajectory A: constant, trajectory B: decreasing and trajectory C: increasing) for a variable X, a patient will be characterized by 3 probabilities of following either trajectory A, B or C. This procedure is particularly interesting for avoiding a loss of information when assigning a patient to a single trajectory while he may transit from one trajectory to another.

For categorical variables (only MINI diagnosis), because it was impossible to apply GMMs, we created a change indicator, making it possible to reflect changes over time. The change indicator was constructed as a categorical variable, which could take 4 different values depending on the 4 possible evolutions between the beginning (T1) and the end (T3) of the follow-up, i.e.: absent at T1 and T3, present only at T1, present only at T3 and present at T1 and T3.

Step 2: Classification of patients

We used latent class analysis (LCA) to classify patients within the final typology. We applied the LCA to assignment probabilities obtained from GMMs and change indicators. We tested several models whose number of classes ranged from 2 to 7. To determine the best number of classes, we used the same 4 criteria as for the GMMs. We used assignment probabilities as outcomes for the LCA.

Descriptions of classes

We used all of the variables collected, both those used in the trajectory analysis (evolving over time) and the others, to describe the classes. To compare each class to the total sample, we performed analyses of variance (ANOVAs) or non-parametric tests for continuous variables and chi-square or Fisher exact tests for categorical variables. The conventional 5% value was used for significance.

Results

Description of the sample

Among the 302 patients included in the analysis, the five disorders were represented in different proportions: ED (43%), PG (35%), SA (14%), EVU (6%) and CB (1%). The proportion of men and women was identical (50%), and the mean age was 34 years. Half of the patients were single (51%), 47% were professionally active, and 36% had an educational level higher than high school graduation. Initiation of the behavior occurred on average at 17 years, and the behavior became problematic approximately 10 years later.

Growth Mixture Models

Table 3 shows the models selected for each score and graphic illustrations of the obtained trajectories are given in Supporting Information (S1S4 Figs). All of the models selected followed linear trends and/or constants.

Table 3. Models obtained for each selected variable with Growth Mixture Model analysis.

n Trajectories forms Sample size of the smallest trajectory (%) SABIC Entropy Number of converging models Number of models with highest LL
UPPS-P
Negative urgency 295 2C DV REIS 18.3 3339.496 0.578 10 4
Lack of premeditation 295 2L1C DV REI 11.5 3204.375 0.556 10 6
Lack of perseverance 295 2L1C DV REI 20.3 3188.490 0.497 10 7
Sensation seeking 295 3L1C DV REI 9.9 3436.635 0.550 10 4
ASRS
Inattention 290 2L1C DV REI 8.1 3608.161 0.534 10 4
Hyperactivity 290 2L1C DV REI 7.6 3578.503 0.506 10 5
TCI
Self-directedness 298 4L DV REI 6.6 6284.298 0.766 10 6
Cooperation 298 1L2C DV REI 23.1 5664.110 0.671 10 4
Self-transcendence 298 4L DV REI 12.3 6209.543 0.659 10 7
Dammage
Health 302 2C EV REI 18.9 3157.642 0.753 10 1
Work/school 293 3C EV REI 7.8 2880.42 0.831 10 5
Relationship 302 1L1C DV REI 7.2 3887.075 0.899 10 7

Notes:

LL: log-likelihood

DV: different residual variances / EV: equal residual variances

REIS: random effect on the intercept and slope / REI: random effect on the intercept only

SABIC: Sample-Size Adjusted Bayesian Information Criteria

For each variable, several growth mixture models composed of 1–4 trajectories were tested using a constant (C), a linear (L) or a quadratic (Q) trend for each trajectory.

The numbers before C and L give the number of trajectories of each type. For example, for the “Inattention” score of the ASRS, “2L1C VD EAI” denotes that the selected model comprised 2 linear and 1 constant trajectories, with different residual variances and a random effect on the intercept only.

Latent class analysis

As shown in Table 4, we selected the 5-class solution, which correctly classified 95.5% of patients.

Table 4. Latent class analysis: Properties of the models composed of 2 to 7 classes.

2 classes 3 classes 4 classes 5 classes 6 classes 7 classes
SABIC 4057.1 3177.7 2880.4 2211.0 2619.9 2084.1
% of patients
    Class 1 92.1 7.9 7.9 4.3 10.0 14.7
    Class 2 8.0 64.5 38.1 30.5 2.6 2.0
    Class 3 - 27.6 18.0 17.6 7.6 6.1
    Class 4 - - 36.0 42.0 22.3 16.5
    Class 5 - - - 5.6 55.5 47.6
    Class 6 - - - - 2.0 7.6
    Class 7 - - - - - 5.5
Entropy 1.000 0.957 0.942 0.955 0.976 0.971

Typologies

After comparison of each class to the total sample, we found that one class (n = 92) significantly emerged for the majority of variables, making it impossible to characterize the other classes. Consequently, first, we compared the class with 92 patients to the total sample (= entire sample) and, second, the four other classes to the total sample except the class with 92 patients (= corrected sample). Descriptions of the classes and p-values of the comparisons performed are given in Table 5.

Table 5. Description of the 5 classes.

Patients with complex psychological functioning
(n = 92)
Patients with impulsive psychological functioning (n = 13) Patients with cooperative psychological functioning (n = 53) Patients with immature psychological functioning (n = 127) Patients with resilient psychological functioning (n = 17) Entire sample
5 classesa
(n = 302)
Corrected sample
4 classesb
(n = 210)
Qualitative variables n % p-value
5 classes
n % p-value
4 classes
n % p-value
4 classes
n % p-value
4 classes
n % p-value
4 classes
n % n %
Type of disorder 0.2448 0.0354 0.1353 0.9272 0.1597
            Compulsive buying 1 1.1 0 0 1 2 1 1 1 6 4 1 3 1
            Sexual addiction 19 20.7 4 31 7 13 11 9 1 6 42 14 23 11
            Problem gambling 22 23.9 7 54 12 22 55 43 11 65 107 35 85 41
            Excessive videogame use 7 7.6 1 8 3 6 7 5 0 0 18 6 11 5
            Eating disorders 43 46.7 1 8 30 57 53 42 4 24 131 43 88 42
Sex 0.9048 0.0027 0.1971 0.9535 0.7864
            Women 45 49 1 8 32 60 65 51 8 47 151 50 106 50
            Men 46 51 12 92 21 40 62 49 9 53 150 50 104 50
Marital status 0.0500 0.0584 0.1053 0.6656 0.7077
            Lives alone 66 72 4 8 38 71 70 56 9 47 187 62 121 58
            Lives in couple 24 26 9 92 15 29 56 44 8 53 113 37 89 42
            Other 2 2 0 0 0 0 0 0 0 0 2 1 0 0
Educational level 0.8923 0.5501 0.4183 0.5026 0.5944
            Under high school graduation 33 36 3 23 15 28 48 38 7 41 106 35 73 35
            Over high school graduation 59 64 10 77 38 72 78 62 10 59 196 65 137 65
Employment situation 0.1172 0.2388 0.7543 0.7192 0.1026
            Inactive 56 62 4 31 26 50 58 46 11 69 155 52 99 48
            Active 35 38 9 69 26 50 67 54 5 31 142 48 107 52
ADHD <0.0001 0.0208 0.2123 0.7905 0.2761
            No ADHD 36 39 7 54 48 90 102 81 12 71 205 68 169 80
            ADHD persistent (adulthood) 39 42 3 23 1 2 6 4 2 12 51 17 12 6
            ADHD no persistent (childhood) 17 19 3 23 4 8 19 15 3 18 46 15 29 14
Total abstinence for at least a month 0.0293 0.3368 0.5075 0.6163 0.8922
            No 64 61 4 36 23 46 67 54 9 53 167 57 103 51
            Yes 28 30 7 64 27 54 57 46 8 47 127 43 99 49
Mood disorders <0.0001 0.1065 0.1754 0.9165 0.0528
            No 10 11 9 69 19 36 57 45 12 71 107 35 97 46
            Yes 82 89 4 31 34 64 70 55 5 29 195 65 113 54
Anxiety disorders <0.0001 0.0509 0.5717 0.7896 0.5438
            No 19 21 11 85 28 52 70 55 11 68 139 46 120 57
            Yes 73 79 2 15 25 48 57 45 6 35 163 54 90 43
Alcohol-related disorders 0.0020 0.4770 0.4483 0.9716 0.7547
            No 51 56 9 69 44 84 101 80 13 76 219 73 168 80
            Yes 41 44 4 31 9 16 26 20 4 24 83 27 42 20
Substance-related disorders 0.0302 0.68880 0.7389 0.7444 >0.999
            No 66 72 11 85 45 84 111 87 15 88 248 82 182 87
            Yes 26 28 2 15 9 16 16 13 2 12 54 18 28 13
Antisocial personality disorder 0.5115 >0.999 0.5865 0.7320 0.3766
            No 88 95 13 100 53 100 123 97 16 94 293 97 205 98
            Yes 4 5 0 0 0 0 3 3 1 6 9 3 5 2
Suicidal risk 0.0030 0.0672 0.6697 0.4055 0.6476
            No 31 34 11 85 34 63 68 54 11 65 155 51 124 59
            Yes 61 66 2 15 19 37 58 46 6 35 147 49 86 41
Patients with complex psychological functioning (n = 92) Patients with impulsive psychological functioning (n = 13) Patients with cooperative psychological functioning (n = 53) Patients with immature psychological functioning (n = 127) Patients with resilient psychological functioning (n = 17) Entire samplev
5 classes1
(n = 302)
Corrected sample
4 classes2
(n = 210)
Quantitative variables Mean ± SD p-value
5 classes
Mean ± SD p-value
4 classes
Mean ± SD p-value
4 classes
Mean ± SD p-value
4 classes
Mean ± SD p-value
4 classes
Mean ± SD Mean ± SD
Age 32.6 ±7.7 0.2645 35.4 ±2.9 0.8622 34.0 ±6.1 0.7034 33.9 ±9.5 0.6476 40.7 ±4.0 0.1718 34.0 ±14.6 34.6 ±12.4
Age of initiation 14.9 ±2.6 <0.0001 15.4 ±0.7 0.0464 18.3 ±3.3 0.5983 17.3 ±4.7 0.4229 21.2 ±2.5 0.2052 16.9 ±7.0 17.8 ±6.4
Age of onset of problems 25.4 ±6.6 0.1134 30.8 ±2.9 0.4926 26.3 ±5.2 0.3051 27.5 ±8.1 0.7863 33.0 ±3.2 0.1514 27.1 ±12.6 27.8 ±10.7
Age of first care 29.9 ±7.7 0.1582 34.4 ±3.1 0.6541 30.0 ±5.9 0.1745 32.0 ±9.8 0.8704 40.5 ±4.1 0.0743 31.6 ±15.0 32.4 ±12.8
Duration (years)
            between initiation and problems 10.5 ±6.5 0.7572 14.7 ±2.7 0.3110 8.1 ±4.2 0.1307 10.2 ±7.2 0.8250 11.8 ±2.6 0.5217 10.2 ±11.2 10.0 ±9.2
            between problems and care 4.7 ±4.1 0.9365 3.6 ±0.6 0.2800 3.6 ±2.6 0.1788 4.7 ±4.3 0.7411 7.5 ±2.4 0.2509 4.6 ±7.0 4.6 ±5.7
            between initiation and care 14.9 ±7.7 0.8503 18.5 ±2.9 0.4219 11.8 ±5.1 0.0766 14.7 ±8.9 0.8141 19.3 ±3.5 0.2083 14.7 ±13.7 14.6 ±11.3
Number of Goodman criteria (addiction severity) 5.4 ±2.0 0.0012 4.0 ±0.7 0.3051 4.3 ±1.6 0.0003 3.4 ±2.3 0.0019 4.7 ±0.4 0.0905 4.3 ±3.7 3.7 ±3.0
WURS-C 52.8 ±9.9 <0.0001 37.3 ±3.7 0.3530 26.9 ±6.4 0.0091 33.7 ±10.9 0.2642 31.1 ±4.5 0.8745 38.3 ±19.8 32.0 ±14.2
RSES 20.7 ±2.8 <0.0001 26.3 ±0.7 0.8304 26.5 ±3.1 0.6699 24.6 ±3.4 0.0001 29.2 ±0.5 0.1605 23.9 ±6.0 25.5 ±4.8
IPAH
            Internal 34.3 ±3.0 0.0629 31.3 ±0.1 0.0061 32.5 ±2.1 0.4865 33.0 ±3.2 0.9946 32.8 ±1.5 0.9688 33.3 ±5.2 32.8 ±4.2
            External—powerful others 30.1 ±3.3 <0.0001 28.3 ±1.3 0.5643 24.2 ±3.9 0.5978 27.0 ±3.8 0.0021 23.7 ±1.4 0.7348 27.3 ±7.0 26.1 ±7.2
            External—luck 30.0 ±3.8 <0.0001 21.5 ±1.2 0.6213 22.7 ±3.5 0.1663 26.7 ±4.1 0.0008 23.2 ±1.2 0.7373 26.7 ±7.4 25.1 ±5.9
DSQ
            Mature 5.4 ±0.6 0.4008 5.9 ±0.3 0.4085 5.5 ±0.5 0.5242 5.5 ±0.8 0.8776 5.8 ±0.3 0.5653 5.5 ±1.2 5.6 ±1.0
            Neurotic 5.3 ±0.7 <0.0001 4.2 ±0.3 0.3239 4.4 ±0.5 0.1844 4.8 ±0.8 0.1571 4.5 ±0.3 0.6841 4.9 ±1.3 4.7 ±1.0
            Immature 5.2 ±0.5 <0.0001 4.2 ±0.3 0.8045 3.6 ±0.4 <0.0001 4.3 ±0.7 0.0288 4.0 ±0.2 0.6951 4.4 ±1.1 4.1 ±0.9
Life events score (cumulative traumatic intensity) 56.0 ±21.6 0.0208 55.0 ±5.0 0.5406 39.5 ±13.7 0.5577 44.2 ±18.9 0.4390 15.0 ±1.3 0.0004 46.3 ±33.4 41.6 ±24.5
Number of life events 10.3 ±3.2 0.9001 8.6 ±0.6 0.6577 8.6 ±2.2 0.3988 9.6 ±3.5 0.3349 8.7 ±1.2 0.5035 9.5 ±5.4 9.2 ±4.4
TCI
            Novelty seeking 59.3 ±11.3 <0.0001 60.8 ±4.4 0.0399 38.8 ±5.6 0.0001 46.0 ±12.5 0.8824 53.5 ±3.5 0.0416 49.9 ±20.2 45.7 ±15.5
            Harm avoidance 67.1 ±13.6 0.0116 46.7 ±4.2 0.0695 58.9 ±10.9 0.8834 61.3 ±15.8 0.3634 54.4 ±5.3 0.3840 61.7 ±24.9 59.3 ±20.6
            Reward dependence 57.8 ±9.1 0.0779 55.0 ±3.2 0.2057 63.5 ±8.0 0.4147 60.6 ±12.6 0.6743 66.3 ±5.0 0.3625 60.3 ±18.7 61.5 ±16.2
            Persistence 47.5 ±17.0 0.0008 46.7 ±6.0 0.1447 59.7 ±13.0 0.7980 63.0 ±19.7 0.3753 57.6 ±6.6 0.6528 56.6 ±31.1 60.7 ±25.4
            Self-directedness 37.6 ±9.1 <0.0001 66.3 ±4.2 0.5521 61.4 ±8.7 0.6956 55.0 ±11.3 <0.0001 64.2 ±4.7 0.7188 51.7 ±20.7 58.1 ±15.9
            Cooperation 68.8 ±9.4 <0.0001 72.3 ±2.9 0.1435 83.9 ±4.4 0.0009 75.4 ±10.1 0.0087 79.1 ±4.0 0.9807 74.9 ±16.2 77.7 ±12.5
            Self-transcendence 39.1 ±12.3 0.0005 27.2 ±4.5 0.9470 23.8 ±8.6 0.2544 31.4 ±13.5 0.0128 29.4 ±5.4 0.6445 32.2 ±22.0 29.1 ±17.7
Maximum abstinence duration (months) 3.5 ±1.7 0.2534 1.9 ±0.2 <0.0001 4.8 ±3.4 0.8450 4.7 ±5.0 0.7950 3.0 ±0.5 0.0210 4.2 ±6.4 4.4 ±6.1
UPPS-P
            Negative urgency 12.0 ±1.4 <0.0001 11.4 ±0.5 0.0122 6.7 ±0.7 <0.0001 10.6 1.7 <0.0001 11.4 ±0.7 0.0123 10.4 ±3.1 9.7 ±2.5
            Lack of premeditation 9.6 ±1.5 <0.0001 9.4 ±0.3 0.0007 7.0 ±0.8 0.0059 7.9 1.4 0.2817 8.3 ±0.7 0.3462 8.3 ±2.5 7.8 ±1.9
            Lack of perseverance 9.5 ±1.4 <0.0001 7.7 ±0.4 0.4744 7.2 ±1.0 0.8826 7.2 1.3 0.9309 7.2 ±0.5 0.9802 7.9 ±2.5 7.2 ±1.7
            Sensation seeking 11.4 ±1.6 <0.0001 11.2 ±0.5 0.0117 8.4 ±1.3 0.0770 9.8 1.8 0.0050 10.4 ±0.5 0.0250 10.1 ±3.0 9.6 ±2.4
ASRS
            Inattention 23.7 ±3.1 <0.0001 15.6 ±1.0 0.4113 14.5 ±2.2 0.9986 14.7 2.8 0.6740 15.5 ±1.8 0.5746 17.6 ±6.6 14.7 ±4.1
            Hyperactivity 19.2 ±3.1 <0.0001 14.8 ±0.9 0.2360 12.4 ±2.4 0.3868 14.2 3.7 0.0536 12.5 ±1.2 0.6408 15.4 ±6.2 13.6 ±4.7
Damages
            Health (/5) 3.8 ±0.6 <0.0001 1.6 ±0.3 0.2141 2.9 ±0.7 0.0002 3.1 1.0 <0.0001 2.1 ±0.4 0.9491 3.1 ±1.5 2.9 ±1.3
            Work/school (/5) 2.1 ±1.1 0.0006 0.8 ±0.3 0.9986 1.7 ±0.8 0.0006 1.1 1.0 0.0302 0.4 ±0.2 0.2165 1.4 ±1.8 1.2 ±1.4
            Relationship (/10) 7.3 ±1.2 <0.0001 1.8 ±0.1 <0.0001 6.1 ±1.0 <0.0001 6.2 1.3 <0.0001 0.4 ±0.1 <0.0001 6.0 ±2.7 5.4 ±2.3

a Total-5 classes corresponds to the entire sample.

b Total-4 classes corresponds to the entire sample except the “complex patients” class, i.e. the “corrected sample”.

Patients with complex psychological functioning

This class contained 92 patients (30%), and significantly emerged from the others, with the majority of the variables being significantly different from the entire sample. The sociodemographic characteristics and distribution of disorders did not differ from the entire sample.

This class displayed the highest rate of inability stopping the problematic behavior for at least one month (61%), largely over the other classes. The age of problematic behavior onset was lower (15 years), with no other difference in the problematic behavior course.

This class was characterized by a more severe symptomatology, with a higher addiction severity and a higher level of disorder-related damage in all domains. This high-severity profile was associated with multiple comorbidities (mood disorders, anxiety disorders, substance use disorders and ADHD) and numerous psychopathological personality traits (low self-esteem, high neurotic and immature defense mechanisms, a high external locus of control, high impulsivity, high novelty seeking and harm avoidance temperaments, a low persistence temperament, low self-directedness and cooperation character traits, and a high transcendence character trait). They experienced a very high rate of suicidal risk (two-thirds of the class) and displayed a higher negative life events score.

All of these arguments led us to define these patients as patients with complex psychological functioning to illustrate their high level of severity in all psychopathological domains explored.

After the exclusion of patients with complex psychological functioning, the corrected sample used for the comparative analyses of the other four classes was reduced to 210 patients.

Patients with impulsive psychological functioning

This class was the smallest, with only 13 patients (4%). These patients presented mostly with PG and SA, and ED were largely underrepresented compared to the other classes.

Men were overrepresented, and the average age of initiation was low. Their internal locus of control score was lower, but the difference did not reach clinical relevance (one-point difference).

We identified an impulsive profile because of three arguments: a higher novelty seeking score, three higher impulsivity scores (lack of premeditation, negative urgency and sensation seeking) and more frequent histories of ADHD. Despite having the highest experimentation of abstinence, patients with impulsive psychological functioning appeared to be less able to durably stop their problematic behavior, with a significantly lower maximum duration of abstinence (half of the entire sample). An unexpected result was that the problematic behavior had less impact on relationships.

Patients with cooperative psychological functioning

This class was composed of 53 patients (18%). The sociodemographic characteristics, distribution of disorders, problematic behavior course and comorbid psychiatric disorders within this class did not differ from the corrected sample. Patients with cooperative psychological functioning were found to have a higher addiction severity than the corrected sample, although this difference was very small (0.6 points out of 9). They displayed a lower childhood ADHD score, a lower immature defense style score and a lower novelty seeking score. They were also characterized by a low level of impulsivity, particularly on the negative urgency and lack of premeditation dimensions. The attribute that best characterized this class was a significantly higher cooperation score. Finally, they declared a higher impact of the problematic behavior, although to a lower extent than for complex patients.

Patients with immature psychological functioning

This class was the most represented, with 127 patients (42%). There were no differences in the sociodemographic characteristics, distribution of disorders, problematic behavior course and comorbid psychiatric disorders. This class had the lowest addiction severity. These patients displayed a lower self-esteem score, a lower cooperation score and a higher transcendence score. They also presented a high impulsive profile, particularly on the negative urgency dimension. The levels of reported damage were lower for the work/school domain and higher for health and relationships domains, but the difference was clinically relevant only for relationships. We identified this class as being patients with immature psychological functioning because of a higher external locus of control, a lower self-directedness score and a higher immature defense style score.

Patients with resilient psychological functioning

This class was the second smallest class, with 17 patients (6%). There were no differences for the sociodemographic characteristics, distribution of disorders, problematic behavior course and comorbid psychiatric disorders. Patients with resilient psychological functioning were high novelty seekers and displayed high levels of impulsivity on the negative urgency and sensation seeking dimensions. They experienced a lower maximum duration of abstinence, although higher than for impulsive patients. We identified the patients from this class as having a resilient psychological functioning because it seemed that they were more efficiently able to cope with problems. One illustration of this point is the low reported level of negative consequences, despite an equivalent or even higher (although not significant) level of addiction severity. Another illustration is the fact that the negative life events score was three times lower than for the other classes, despite an equivalent number of experienced life events and no difference in age.

Fig 2 is an attempt to summarize the main characteristics of each class.

Fig 2. Schematic representation of the five types of patients with behavioral addictions or eating disorders.

Fig 2

(+) High level of the characteristic (relative to the other classes). (-) Low level of the characteristic (relative to the other classes). The (+) and (-) have been positioned to indicate a high level of psychopathology on the right column and a low level on the left column. For example, patients with impulsive psychological functioning have a high capacity to achieve a one-month period of abstinence, which was associated with a low level of psychopathology, but a low capacity to maintain abstinence (low duration), which was associated with a high level of psychopathology. Patients with complex psychological functioning presented with the highest severity, the highest disorder-related damage, the highest level of psychiatric and addictive comorbidity, the highest suicidal risk, the highest level of impulsivity, and the lowest capacity to achieve a one-month period of abstinence, giving a multiple-psychopathological profile.

Discussion

Trajectory analyses have rarely been used in the context of BAs, except for some studies on PG [10, 12], and have been little used for EDs [11, 13]. To the best of our knowledge, our study is the first to use growth mixture modeling followed by latent class analysis, making it possible to identify five classes of patients with BAs or EDs characterized by different trajectories during a one-year period of specialized care. This kind of approach has lead both to discuss the similarities of the clinical trajectories between the BAs with each other and with EDs, and to clinical implications for care management.

Similarities of the clinical trajectories between the BAs with each other and with EDs

As stated in the introduction, we expected to obtain one of the following typologies: (i) a common care trajectory for all studied disorders (both BAs and EDs), (ii) a distinct trajectory for each type of disorder, or (iii) different trajectories independent of the type of disorder. The last hypothesis was confirmed, with a final typology not linked to the type of disorder, but rather, based on the profiles of patients. Indeed, we did not identify any significant grouping of disorders within any class of the typology. The only class that demonstrated a differential repartition of disorders was the “impulsive patients” class, which was also the least represented class. It should be noted that, despite the fact that EVU and EDs are not consensually included in the framework of addictions, these disorders did not group separately from the other BAs. A previous study demonstrated that a subgroup of individuals with EDs displayed an “addictive-like” ED and share some addictive personality traits with substance-related disorders [5]. Our study supports this statement on a longitudinal perspective, by showing common trajectories between EDs and BAs, even for the restrictive type of anorexia nervosa which was found to have lower rates of “addictive-like” ED [5]. Moreover, the 11th revision of the International Classification of Diseases (ICD-11) has recently proposed to include “gaming addiction” under the “disorders due to addictive behaviors” category, thus supporting EVU belongs to the spectrum of BAs [49], even if debate is still open on the level of evidence [50]. As for EDs, our result of common clinical trajectories between EVU and other BAs seems to support the ICD-11 view, although further studies are needed to compare those trajectories with other addictions such as substance-related disorders. In conclusion, the absence of a grouping of the different disorders in the typology allows us to envisage a transversality of the evolutionary profiles between the different forms of BAs and EDs. Therefore, this suggests the relevance of a common addictive concept applicable both to all BAs, including those for which the inclusion under the addictive disorder label is not consensual (such as problematic videogame use or sexual addiction), and also to EDs.

The second conclusion of this work is that there was no clear overlap of the obtained typology with previous theoretical models of BAs or EDs, based on psychological characteristics. For EDs, the theoretical model of eating disorder development is referred as the dual pathway model [51, 52]. However, such model mainly focused on ED symptomatology (dietary restraint and bulimic symptoms), which does not allow for comparisons with other disorders. Furthermore, other works aiming at identifying longitudinal ED trajectories or pathways [11, 13] also explored ED symptoms (variation of weight, change in dietary or eating behaviors, body shape concerns, etc.), rather than psychological characteristics or psychiatric comorbidities. To the best of our knowledge, such a model based on psychological vulnerabilities not directly related to the symptomatology of the disorder only exists in the framework of PG, with the well-known pathway model [53]. This model presumes that there are three distinct types of problem gamblers, with implications for clinical management. Behaviorally conditioned problem gamblers are characterized by the absence of any premorbid psychopathology. Emotionally vulnerable problem gamblers are characterized by premorbid anxiety and/or depression, poor coping skills and negative life events. Antisocial/impulsivist problem gamblers are highly disturbed individuals, with high levels of impulsivity and maladaptive behaviors. If some features of this model can partially overlap with the present typology, this type of theoretical typology does not seem to be applicable to all disorders included in this study. As a consequence, we think that the proposed typology in five classes may provide additional knowledge on the typical pathways of patients with BAs and EDs.

Clinical implications for the management of BAs and EDs

General implications

As stated in the introduction, given that we obtained different trajectories not linked to the type of disorder but, rather, based on patient profiles (profiles of personality, psychiatric comorbidities, etc.), it is possible to envisage the use of common therapeutic tracks independently of the disorder, targeted on individual vulnerabilities (personalized medicine), rather than care only centered on the problematic behavior. This may allow achieving a subject-centered rather than an object-centered clinical approach. Care management of BAs and EDs may benefit from a dual-approach based on the use of therapies that has demonstrated relatively good efficiency for the various addictive and eating disorders (motivational interviewing and cognitive-behavioral therapies (CBT), for example), supplemented by specific approaches focusing on the individual vulnerabilities of each profile from the typology. This may allow patients to partly distance themselves from their problematic behavior and to work on the mechanisms underlying their addictive vulnerability. Consequently, addiction care providers should feel legitimate in managing the various addictive and eating disorders, and addictology departments receiving patients suffering from all types of addictions or eating disorders should be promoted.

Clinical implications of the five-class typology

Patients with complex psychological functioning were deeply affected in various domains. Such patients may demonstrate poorer responses to care and less compliance. The complexity of patients in health care has received increasingly more attention from care providers [54, 55]. Achieving congruence between the patient and the care provider is of crucial importance for effective, patient-centered care [54]. The difficulty lies in the management of the multiplicity of associated disorders, together with psychopathological personality traits and negative life events. A possible approach would be to first direct the therapeutic work more to the psychiatric comorbidities, which seem to be very pregnant in this class, rather than to the problematic behavior itself. Indeed, psychiatric comorbidities have been found to increase the risk of relapse and to worsen the prognosis in other substance-related addictive disorders [56], so that appropriate treatment of such comorbidities can significantly improve long-term prognosis and functioning in multiple domains. As a consequence, treating psychiatric comorbidities in patients with complex psychological functioning should be considered a key goal andmay secondarily improve the other psychopathological characteristics (self-esteem, abstinence capacity) and their intrinsic motivation to change, and help the patient be more receptive to addictive care in a second time, in a virtuous cycle of recovery. Because they display a very high rate of suicidal risk and a high level of disorder-related damage, harm reduction should also be provided to limit the negative consequences of the behavior. Finally, mental health providers should keep in mind that access to addiction treatment for these patients with multiple comorbidities may be done through the co-occurring disorders. A systematic screening of addictions (substance-related or not) and EDs should be promoted for all patients presenting for a mental health problem.

Patients with impulsive psychological functioning unexpectedly reported lower damage from the disorder. This finding may be due to a low addiction severity or the fact that they have less awareness of the negative impacts on their lives (lower insight). This class was the smallest one, which may indirectly indicate that they have more difficulty accessing specialized care, especially due to a lower awareness of disorder-related damage. Such a profile of patients does not seek for care easily but may benefit from impulsivity-centered care, focused on the reduction of stress reactivity or the enhancement of coping strategies with psychotherapies and/or the regulation of their biologically-based impulsivity with psychotropic medications [53]. This would be the first step toward favoring care compliance and the durability of abstinence.

In contrast, patients with cooperative psychological functioning reported a slightly higher severity of the addiction, which could reflect a higher awareness of the negative impacts on their lives (higher insight). This could represent a therapeutic lever for these patients because their high cooperativeness may lead them to attempt to solve their problems. Solution-oriented therapies focused on the experienced damage may thus represent an efficient care strategy for these patients.

Patients with immature psychological functioning displayed global weak maturity characterized by a lower ability to appropriately adapt behavior to the situation and the attribution of the causality of events to external causes. Care should focus on the correction of external attribution with the reinforcement of self-esteem and personal skills and on the enhancement of coping strategies.

Finally, patients with resilient psychological functioning were characterized by presumed good coping skills, with a low level of reported damage and negative impact from traumatic events. Such patients may benefit from shorter interventions such as support groups (such as Gamblers Anonymous) or CBT, supplemented by relapse prevention programs.

Limitations

Some limitations of this study should be noted. First, because the patients with complex psychological functioning class was marked by an extreme level of pathology, it has erased the characteristics of the four other classes. We have attempted to overcome this problem by conducting two separate analyses to describe the classes, with and without these patients. However, it is debatable whether this decision has brought biased results. Second, certain classes (patients with impulsive and resilient psychological functioning) or clinical groups (compulsive buyers) sample sizes were low, which limits the interpretability. Third, we included only patients seeking care and with three time points of evaluation, which could have resulted in a selection bias. Indeed, it is well-known that help-seeking is very low in patients suffering from addictions, both substance-related or not [57, 58]. Moreover, it is assumed that some types of patients, such as impulsive patients, are not very compliant with care [53]. By definition, these patients would therefore be unlikely to be included in our study. Fourth, we have mainly focused on individual vulnerabilities rather than on environmental vulnerabilities, which may have had an impact on the typology obtained and should be taken into account for care management. Moreover, some individual vulnerabilities or frequent comorbid conditions, such as personality disorders, have not been assessed. These choices were made because of the long duration of the EVALADD interviews and the time needed to complete questionnaires at home. The clinical characteristics investigated have thus been reduced to a minimum acceptable both in terms of clinical relevance and duration of assessment, to ensure acceptability of the procedure from patients and especially to maximize the follow-up retention rate. Finally, we made the choice to include all EDs, EVU and subclinical disorders within the framework of this work. As stated in the introduction, these disorders are not consensually linked to the concept of addiction. However, the fact that the typology did not identify these disorders separately could indicate that separating them is no more legitimate than bringing them together.

Conclusions

To the best of our knowledge, this study is the first attempt to determine the typology of patients with behavioral addictions or eating disorders in a large range of disorders and based on a one-year period of evolution. The typology obtained brings interesting findings to propose patient-centered care strategies adapted to these profiles. Because the typology was independent from the type of disorder, it supports the general concept of addiction for all BAs, including several disorders such as gambling disorder, sexual addiction, and compulsive buying as well as excessive videogame use. It also supports the relevance of exploring the addictive nature of eating disorders, and the overlap between the two categories of disorders. The relevance of this model should be further examined in future studies.

Supporting information

S1 Fig. Graphic representations of the latent trajectories obtained for the 4 UPPS-P dimensions after the Growth Mixture Models analysis.

(DOCX)

S2 Fig. Graphic representations of the latent trajectories obtained for the 2 ASRS dimensions after the Growth Mixture Models analysis.

(DOCX)

S3 Fig. Graphic representations of the latent trajectories obtained for the 3 character dimensions of the TCI after the Growth Mixture Models analysis.

(DOCX)

S4 Fig. Graphic representations of the latent trajectories obtained for the 3 damage scores after the Growth Mixture Models analysis.

(DOCX)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This study is part of the EVALADD cohort, which is sponsored by the Centre Hospitalier Universitaire de Nantes (CHU Nantes).

References

  • 1.Goodman A. Neurobiology of addiction. An integrative review. Biochem Pharmacol. 2008;75(1):266–322. 10.1016/j.bcp.2007.07.030 . [DOI] [PubMed] [Google Scholar]
  • 2.Granero R, Fernandez-Aranda F, Mestre-Bach G, Steward T, Bano M, Del Pino-Gutierrez A, et al. Compulsive Buying Behavior: Clinical Comparison with Other Behavioral Addictions. Frontiers in Psychology. 2016;7:914 10.3389/fpsyg.2016.00914 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Markey PM, Ferguson CJ. Internet Gaming Addiction: Disorder or Moral Panic? American Journal of Psychiatry. 2017;174(3):195–6. 10.1176/appi.ajp.2016.16121341 . [DOI] [PubMed] [Google Scholar]
  • 4.American Psychiatric Association. Diagnostic and statistical manual of mental health disorders: DSM-5 5th ed Washington DC: American Psychiatric Publishing; 2013. [Google Scholar]
  • 5.Speranza M, Revah-Levy A, Giquel L, Loas G, Vénisse JL, Jeammet P, et al. An investigation of Goodman's addictive disorder criteria in eating disorders. Eur Eat Disorders Rev. 2012;20(3):182–9. 10.1002/erv.1140 . [DOI] [PubMed] [Google Scholar]
  • 6.Grall-Bronnec M, Sauvaget A. The use of repetitive transcranial magnetic stimulation for modulating craving and addictive behaviours: A critical literature review of efficacy, technical and methodological considerations. Neurosci Biobehav Rev. 2014;47:592–613. 10.1016/j.neubiorev.2014.10.013 [DOI] [PubMed] [Google Scholar]
  • 7.Beitscher-Campbell H, Blum K, Febo M, Madigan MA, Giordano J, Badgaiyan RD, et al. Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic. Journal of Behavioral Addictions. 2016;5(3):533–41. 10.1556/2006.5.2016.055 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Goodman A. Addiction: definition and implications. Br J Addict. 1990;85(11):1403–8. . [DOI] [PubMed] [Google Scholar]
  • 9.Merkouris SS, Thomas SA, Browning CJ, Dowling NA. Predictors of outcomes of psychological treatments for disordered gambling: A systematic review. Clin Psychol Rev. 2016;48:7–31. 10.1016/j.cpr.2016.06.004 . [DOI] [PubMed] [Google Scholar]
  • 10.Bruneau M, Grall-Bronnec M, Venisse JL, Romo L, Valleur M, Magalon D, et al. Gambling transitions among adult gamblers: A multi-state model using a Markovian approach applied to the JEU cohort. Addictive Behaviors. 2016;57:13–20. 10.1016/j.addbeh.2016.01.010 . [DOI] [PubMed] [Google Scholar]
  • 11.Peterson CB, Swanson SA, Crow SJ, Mitchell JE, Agras WS, Halmi KA, et al. Longitudinal stability of binge-eating type in eating disorders. International Journal of Eating Disorders. 2012;45(5):664–9. 10.1002/eat.22008 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Carbonneau R, Vitaro F, Brendgen M, Tremblay RE. Trajectories of gambling problems from mid-adolescence to age 30 in a general population cohort. Psychology of Addictive Behaviors. 2015;29(4):1012–21. 10.1037/adb0000102 . [DOI] [PubMed] [Google Scholar]
  • 13.Slane JD, Klump KL, McGue M, Iacono WG. Developmental trajectories of disordered eating from early adolescence to young adulthood: A longitudinal study. International Journal of Eating Disorders. 2014;47(7):793–801. 10.1002/eat.22329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.American Psychiatric Association. DSM-IV-TR. Diagnostic and statistical manual of mental disorders (4 th ed, text revision). Washington DC: American Psychiatric Association; 2000. [Google Scholar]
  • 15.Challet-Bouju G, Hardouin JB, Vénisse JL, Romo L, Valleur M, Magalon D, et al. Study protocol: the JEU cohort study–transversal multiaxial evaluation and 5-year follow-up of a cohort of French gamblers. BMC Psychiatry. 2014;14:226 10.1186/s12888-014-0226-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Guillou-Landreat M, Guilleux A, Sauvaget A, Brisson L, Leboucher J, Remaud M, et al. Factors associated with suicidal risk among a French cohort of problem gamblers seeking treatment. Psychiatry Res. 2016;240:11–8. 10.1016/j.psychres.2016.04.008 . [DOI] [PubMed] [Google Scholar]
  • 17.Gaboriau L, Victorri-Vigneau C, Gerardin M, Allain-Veyrac G, Jolliet-Evin P, Grall-Bronnec M. Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports. Addictive Behaviors. 2014;39(3):562–5. 10.1016/j.addbeh.2013.11.005 . [DOI] [PubMed] [Google Scholar]
  • 18.Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101 Suppl 1:142–51. 10.1111/j.1360-0443.2006.01591.x . [DOI] [PubMed] [Google Scholar]
  • 19.Toce-Gerstein M, Gerstein DR, Volberg RA. A hierarchy of gambling disorders in the community. Addiction. 2003;98(12):1661–72. . [DOI] [PubMed] [Google Scholar]
  • 20.Toneatto T, Millar G. Assessing and treating problem gambling: empirical status and promising trends. Canadian Journal of Psychiatry. 2004;49(8):517–25. 10.1177/070674370404900803 . [DOI] [PubMed] [Google Scholar]
  • 21.Lecrubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Harnett Sheehan K, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry. 1997;12(5):224–31. 10.1016/S0924-9338(97)83296-8. [DOI] [Google Scholar]
  • 22.Tejeiro Salguero RA, Moran RM. Measuring problem video game playing in adolescents. Addiction. 2002;97(12):1601–6. . [DOI] [PubMed] [Google Scholar]
  • 23.Tejeiro RA, Gómez-Vallecillo JL, Pelegrina M, Wallace A, Emberley E. Risk Factors Associated with the Abuse of Video Games in Adolescents. Psychology. 2012;3(4):310–4. 10.4236/psych.2012.34044 [DOI] [Google Scholar]
  • 24.Carnes P. Out of the shadows: understanding sexual addictions. Minneapolis: Editions Compcare Publishers; 1983. [Google Scholar]
  • 25.McElroy SL, Keck PE Jr., Pope HG Jr., Smith JM, Strakowski SM. Compulsive buying: a report of 20 cases. Journal of Clinical Psychiatry. 1994;55(6):242–8. . [PubMed] [Google Scholar]
  • 26.Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. American Journal of Psychiatry. 1993;150(6):885–90. 10.1176/ajp.150.6.885 . [DOI] [PubMed] [Google Scholar]
  • 27.Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245–56. 10.1017/S0033291704002892 . [DOI] [PubMed] [Google Scholar]
  • 28.Cloninger CR. The Temperament and Character Inventory-125 (TCI-125; version 1). St. Louis: Washington University, Center for Psychobiology of Personality; 1992. [Google Scholar]
  • 29.Whiteside SP, Lynam DR. The Five Factor Model and impulsivity: using a structural model of personality to understand impulsivity. Personality and Individual Differences. 2001;30(4):669–89. 10.1016/S0191-8869(00)00064-7. [DOI] [Google Scholar]
  • 30.Billieux J, Rochat L, Ceschi G, Carre A, Offerlin-Meyer I, Defeldre AC, et al. Validation of a short French version of the UPPS-P Impulsive Behavior Scale. Comprehensive Psychiatry. 2012;53(5):609–15. 10.1016/j.comppsych.2011.09.001 . [DOI] [PubMed] [Google Scholar]
  • 31.Rosenberg M. Society and the Adolescent Self-image. Princeton: Princeton University Press; 1965. 560–2 p. [Google Scholar]
  • 32.Levenson H. Multidimensional locus of control in psychiatric patients. J Consult Clin Psychol. 1973;41(3):397–404. . [DOI] [PubMed] [Google Scholar]
  • 33.Bond M. Empirical studies of defense style: relationships with psychopathology and change. Harvard Review of Psychiatry. 2004;12(5):263–78. 10.1080/10673220490886167 . [DOI] [PubMed] [Google Scholar]
  • 34.Ferreri M, Vacher J, Tawils S, Alby JM. Life events and depression. A new methodological approach [Facteurs événementiels et dépression: le questionnaire EVE, une nouvelle approche de méthodologie prédictive]. Psychologie médicale. 1987;19(13):2441–8. [Google Scholar]
  • 35.Caci H, Bouchez J, Baylé FJ. An aid for diagnosing attention-deficit/hyperactivity disorder at adulthood: psychometric properties of the French versions of two Wender Utah Rating Scales (WURS-25 and WURS-K). Comprehensive Psychiatry. 2010;51(3):325–31. 10.1016/j.comppsych.2009.05.006. [DOI] [PubMed] [Google Scholar]
  • 36.Caci H, Bayle FJ, Bouchez J. Adult ADHD: Translation and factor analysis of the ASRS-1.1. European Psychiatry. 2008;23, Supplement 2(0):S367–S8. 10.1016/j.eurpsy.2008.01.1272 [DOI] [Google Scholar]
  • 37.Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50(12):975–90. 10.1001/archpsyc.1993.01820240059008 . [DOI] [PubMed] [Google Scholar]
  • 38.Chakroun-Vinciguerra N, Faytout M, Pélissolo A, Swendsen J. Validation française de la version courte de l'Inventaire du Tempérament et du Caractère (TCI-125). Journal de Thérapie Comportementale et Cognitive. 2005;15(1):27–33. 10.1016/S1155-1704(05)81209-1. [DOI] [Google Scholar]
  • 39.Van der Linden M, D’Acremont M, Zermatten A, Jermann F, Larøi F, Willems S, et al. A French Adaptation of the UPPS Impulsive Behavior Scale: Confirmatory Factor Analysis in a Sample of Undergraduate Students. European Journal of Psychological Assessment. 2006;22(1):38–42. 10.1027/1015-5759.22.1.38 [DOI] [Google Scholar]
  • 40.Vallieres EF, Vallerand RJ. Traduction et validation canadienne-française de l'échelle d'estime de soi de Rosenberg. International Journal of Psychology. 1990;25(2):305–16. 10.1080/00207599008247865 [DOI] [Google Scholar]
  • 41.Jutras S. L'IPAH, version canadienne-française de l'échelle de Levenson mesurant le lieu de contrôle tridimensionnel. [The IPAH, the French-Canadian version of Levenson's scale measuring tridimensional locus of control.]. Canadian Journal of Behavioural Science/Revue canadienne des sciences du comportement. 1987;19(1):74–85. 10.1037/h0079871 PubMed PMID: 1987-30132-001. [DOI] [Google Scholar]
  • 42.Guelfi JD, Hatem N, Damy C, Corruble E. Intérêt du Défense Style Questionnaire (DSQ), questionnaire sur les mécanismes de défense. Annales Médico-Psychologiques. 2000;158:594–601. [Google Scholar]
  • 43.Muthén LK, Muthén BO. Mplus user's guide: Seventh Edition. Los Angeles: Muthén & Muthén; 2012. [Google Scholar]
  • 44.Muthen B, Shedden K. Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrics. 1999;55(2):463–9. . [DOI] [PubMed] [Google Scholar]
  • 45.Sclove SL. Application of model-selection criteria to some problems in multivariate analysis. Psychometrika. 1987;52(3):333–43. 10.1007/BF02294360 [DOI] [Google Scholar]
  • 46.Hipp JR, Bauer DJ. Local solutions in the estimation of growth mixture models. Psychol Methods. 2006;11(1):36–53. 10.1037/1082-989X.11.1.36 . [DOI] [PubMed] [Google Scholar]
  • 47.Bauer DJ, Curran PJ. Distributional assumptions of growth mixture models: implications for overextraction of latent trajectory classes. Psychol Methods. 2003;8(3):338–63. 10.1037/1082-989X.8.3.338 . [DOI] [PubMed] [Google Scholar]
  • 48.Ram N, Grimm KJ. Growth Mixture Modeling: A Method for Identifying Differences in Longitudinal Change Among Unobserved Groups. Int J Behav Dev. 2009;33(6):565–76. 10.1177/0165025409343765 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Rumpf HJ, Achab S, Billieux J, Bowden-Jones H, Carragher N, Demetrovics Z, et al. Including gaming disorder in the ICD-11: The need to do so from a clinical and public health perspective. Journal of Behavioral Addictions. 2018:1–6. 10.1556/2006.7.2018.59 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.van Rooij AJ, Ferguson CJ, Colder Carras M, Kardefelt-Winther D, Shi J, Aarseth E, et al. A weak scientific basis for gaming disorder: Let us err on the side of caution. Journal of Behavioral Addictions. 2018;7(1):1–9. 10.1556/2006.7.2018.19 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Maraldo TM, Zhou W, Dowling J, Vander Wal JS. Replication and extension of the dual pathway model of disordered eating: The role of fear of negative evaluation, suggestibility, rumination, and self-compassion. Eating Behaviors. 2016;23:187–94. 10.1016/j.eatbeh.2016.10.008 . [DOI] [PubMed] [Google Scholar]
  • 52.Stice E, Nemeroff C, Shaw HE. Test of the Dual Pathway Model of Bulimia Nervosa: Evidence for Dietary Restraint and Affect Regulation Mechanisms. Journal of Social and Clinical Psychology. 1996;15(3):340–63. 10.1521/jscp.1996.15.3.340 [DOI] [Google Scholar]
  • 53.Blaszczynski A, Nower L. A pathways model of problem and pathological gambling. Addiction. 2002;97(5):487–99. . [DOI] [PubMed] [Google Scholar]
  • 54.Safford MM, Allison JJ, Kiefe CI. Patient complexity: more than comorbidity. the vector model of complexity. J Gen Intern Med. 2007;22 Suppl 3:382–90. 10.1007/s11606-007-0307-0 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Meller W, Specker S, Schultz P, Kishi Y, Thurber S, Kathol R. Using the INTERMED complexity instrument for a retrospective analysis of patients presenting with medical illness, substance use disorder, and other psychiatric illnesses. Annals of Clinical Psychiatry. 2015;27(1):38–43. . [PubMed] [Google Scholar]
  • 56.Stephen Rich J, Martin PR. Co-occurring psychiatric disorders and alcoholism. Handb Clin Neurol. 2014;125:573–88. 10.1016/B978-0-444-62619-6.00033-1 . [DOI] [PubMed] [Google Scholar]
  • 57.Suurvali H, Cordingley J, Hodgins DC, Cunningham J. Barriers to seeking help for gambling problems: a review of the empirical literature. Journal of Gambling Studies. 2009;25(3):407–24. 10.1007/s10899-009-9129-9 . [DOI] [PubMed] [Google Scholar]
  • 58.Rapp RC, Xu J, Carr CA, Lane DT, Wang J, Carlson R. Treatment barriers identified by substance abusers assessed at a centralized intake unit. J Subst Abuse Treat. 2006;30(3):227–35. 10.1016/j.jsat.2006.01.002 . [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Fig. Graphic representations of the latent trajectories obtained for the 4 UPPS-P dimensions after the Growth Mixture Models analysis.

(DOCX)

S2 Fig. Graphic representations of the latent trajectories obtained for the 2 ASRS dimensions after the Growth Mixture Models analysis.

(DOCX)

S3 Fig. Graphic representations of the latent trajectories obtained for the 3 character dimensions of the TCI after the Growth Mixture Models analysis.

(DOCX)

S4 Fig. Graphic representations of the latent trajectories obtained for the 3 damage scores after the Growth Mixture Models analysis.

(DOCX)

Data Availability Statement

All relevant data are within the paper and its Supporting Information files.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES